Related Experiment Video
Updated: Nov 13, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Biological effects of NODAL on endometrial cancer cells and its underlying mechanisms
Xiaoshan Hong1, Bin Wen1, Huaming Zhang1
1Department of Gynecology, Guangdong Women and Children Hospital, Guangzhou, Guangdong 510010, P.R. China.
Abstract:
Activin A receptor type 1C (ALK7) and its ligand nodal growth differentiation factor (NODAL) serve numerous roles in cancer cells, including regulating cancer invasion, migration and apoptosis. NODAL promotes breast cancer cell apoptosis by activating ALK7; however, ALK7 and NODAL expression in endometrial cancer (EC), as well as their effects and underlying mechanisms in EC cells, are not completely understood. The present study aimed to characterize the expression of NODAL and ALK7 in EC, as well as the underlying mechanisms. The expression levels of ALK7 and NODAL were detected via reverse transcription-quantitative PCR and western blotting. Cell transfection was performed to overexpress NODAL or interfere ALK7. Cell proliferation, invasion and migration were detected via Cell Counting Kit-8, Transwell and wound healing assays, respectively. Flow cytometry was performed to detect cell apoptosis and western blotting was conducted to detect the expression levels of apoptosis-related proteins. NODAL and ALK7 expression levels were significantly decreased in EC cell lines compared with normal endometrial cells. NODAL overexpression inhibited EC cell proliferation, invasion and migration, and promoted EC cell apoptosis compared with the overexpression-negative control (Ov-NC) group. Moreover, NODAL overexpression significantly increased ALK7 expression levels in EC cells compared with the Ov-NC group. ALK7 reversed NODAL overexpression-mediated inhibition of EC cell proliferation, invasion and migration, and promotion of EC cell apoptosis. The present study indicated that NODAL inhibited EC cell proliferation, invasion and migration, and promoted EC cell apoptosis by activating ALK7.
Insights
Nodal growth differentiation factor (NODAL) and activin A receptor type 1C (ALK7) are decreased in endometrial cancer. NODAL inhibits cancer progression and promotes apoptosis by activating ALK7, suggesting a therapeutic target for endometrial cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Activin A receptor type 1C (ALK7) and its ligand, nodal growth differentiation factor (NODAL), are implicated in cancer cell functions like invasion, migration, and apoptosis.
- While NODAL promotes breast cancer cell apoptosis via ALK7 activation, their specific roles and mechanisms in endometrial cancer (EC) remain unclear.
Purpose of the Study:
- To investigate the expression of NODAL and ALK7 in endometrial cancer (EC) cells.
- To elucidate the underlying mechanisms of NODAL and ALK7 in regulating EC cell proliferation, invasion, migration, and apoptosis.
Main Methods:
- Quantitative PCR and western blotting were used to assess ALK7 and NODAL expression levels.
- Cell proliferation, invasion, and migration were evaluated using Cell Counting Kit-8, Transwell, and wound healing assays, respectively.
- Apoptosis and related protein expression were analyzed via flow cytometry and western blotting following NODAL overexpression or ALK7 interference.
Main Results:
- NODAL and ALK7 expression levels were significantly lower in EC cell lines compared to normal endometrial cells.
- NODAL overexpression suppressed EC cell proliferation, invasion, and migration, while enhancing apoptosis.
- NODAL overexpression led to increased ALK7 expression, and ALK7 interference reversed the inhibitory effects of NODAL on EC cells.
Conclusions:
- NODAL inhibits endometrial cancer cell proliferation, invasion, and migration.
- NODAL exerts its tumor-suppressive effects in EC by activating ALK7.
- The NODAL-ALK7 pathway represents a potential therapeutic target for endometrial cancer treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Oogenesis
Non-Canonical Wnt Signaling Pathways

